LAS VEGAS – Pregnancy outcomes can be excellent in women with lupus, but they need help to make sure everything goes okay.
Rheumatologist Dr. Jennifer Grossman, director of lupus clinical...
BRISBANE, AUSTRALIA – A 3-year randomized, controlled trial of annual chlamydia screening in 16- to 29-year-olds has shown that despite a significant increase in testing rates and diagnoses,...
Recurrence rates of ductal carcinoma in situ (DCIS ) have declined significantly over 3 decades, with the improvements likely because of better screening and pathologic assessment, investigators...
Certain combinations of complications during pregnancy raise the mother’s risk of premature cardiovascular disease–related death decades later by as much as sevenfold, according to a report published...
The 8th U.S. Circuit Court of Appeals has ruled against the Affordable Care Act’s contraception mandate, making it likely that the U.S. Supreme Court will revisit the requirement to resolve a split...
Women with lobular carcinoma in situ (LCIS) showed a 2% annual risk of developing breast cancer, and women who chose chemoprevention reduced their annual cancer rate to less than 1%, in a...
Several differences between black and white women in the genotypic traits of their breast tumors have been identified and may explain, at least in part, the greater aggressiveness of breast cancer in...
The risk of recurrence continues to rise for at least 12 years among patients with low-risk DCIS who forgo radiotherapy after undergoing lumpectomy, investigators reported online Sept. 14 in Journal...
SEATTLE – Biomarkers may soon join other modalities for the early detection of breast cancer and identification of women at high risk for the disease, Susan L. Neuhausen, Ph.D., told attendees of the...